The EHRs (Electronic Health Records) Incentive Program run by the CMS (Centers for Medicare and Medicaid Services) garnered attention again previous week following the issue of a report by the Office of Inspector General of the US Department of Health and Human Services (OIG) explaining incorrect payments to physicians under the program. On the heels of a high-profile settlement, the report follows under the False Claims Act between the US Department of Justice and an EHR vendor regarded to certified electronic health record technology (CEHRT) used in the EHR Incentive Program.
New identification cards will be getting by Medicare Beneficiaries that are more secure beginning next year, the CMS (Centers for Medicare & Medicaid Services) said.
A proposed rule has been published by CMS (Centers for Medicare & Medicaid Services) to develop fiscal year (FY) 2018 Medicare hospice reimbursement rates, upgrade the hospice quality programs, and request public input on ways to make better the Medicare hospice program.
Proposed guidelines have been set out by Centers for Medicare and Medicaid Services (CMS) for collecting and submitting quality data through electronic health records (EHRs) systems for the years of 2017 and 2018, indicating certain flexibility in meeting industry demands regarding collection periods.
Almost half of the health plans offering Medicare prescription drug benefits has been slapped by CMS (Centers for Medicare & Medicaid Services) with fines for improperly refusing beneficiaries access to drugs and other services
CMS (Centers for Medicare and Medicaid Services) recently proposed updates for the Medicare Advantage and Part D Prescription Drug Programs in the year of 2018, according to an Advance Notice and Draft Call Letter. In accordance to a press release, if the changes and modifications are finalized they will offer fair and stable payments to plans.
The final rules have been issued by Centers for Medicare and Medicaid Services (CMS) governing home health agencies under Medicare and Medicaid that involve a mix of manual and electronic informational and record-keeping provisions, along with various streamlining requirements that assist home health providers.
An international or global leader in rapid diagnostic tests, Alere, today issued an update on the decision by the Centers for Medicare & Medicaid Services (CMS) to revoke Arriva Medical's Medicare billing privileges of Arrive Medical. Arriva is considered to be the largest Contract Supplier under the Medicare National Mail Order Competitive Bid Program for Diabetes Testing Supplies, having achieved agreements in every round of bidding and demonstrating its trusted supplier status to Centers for Medicare & Medicaid Services (CMS). An appeal has been filed by the Arriva with the Administrative Law Judge (ALJ) at CMS seeking to reinstate billing status of Arriva. Arriva hopes that the ALJ to hear the appeal within thirty days and release a decision within 3 months. The following statement has been issued by Arriva:
A controversial proposal has been dropped by the Obama administration to overhaul how Medicare reimburses doctors for drugs, after pharmaceutical groups and physicians rallied against it.
Several doctors who dispense drugs in their offices or outpatient environments, like oncologists, said they stood to lose under the proposal. In Medicare Part B, which covers care in offices and outpatient settings of doctors, doctors are paid 6 percent above average wholesale prices of drugs. The administration proposed decreasing that percentage in few cases and adding a flat fee to its payments to doctors, with the target of decreasing the financial incentive to prescribe more-costly medicines.